Medication info
Painless Sustained Release Tablet

Painless Sustained Release Tablet

Prescription medicationTabletOral
Ingredient · strength
Acetaminophen›325mg / 1 tabletTramadol Hydrochloride›75mg / 1 tablet
Manufacturer / importer
Genewon Science Co., Ltd.
Appearance
Light yellow oblong sustained-release film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201501690 · Approved 2015.03.30 · Insurance code 671704620

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults
Adult dose
Adults: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 1 tablet is recommended, and subsequent doses should be taken at intervals of at least 12 hours; do not exceed 4 tablets daily. Do not administer this medicine for longer than necessary. If prolonged administration is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued. Nausea, vomiting, itching, constipation, dizziness, and drowsiness may occur during administration; closely monitor the patient's response and adjust the dose as appropriate. Elderly: Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to elderly patients aged 75 years or older, administer this medicine at intervals of at least 12 hours. Patients with renal impairment: The safety and efficacy of this medicine have not been established in patients with renal impairment; therefore, its use is not recommended. Patients with hepatic impairment: The safety and efficacy of this medicine have not been established in patients with hepatic impairment; therefore, its use is not recommended.

Ingredients

Manufacturer
Genewon Science Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate to severe acute pain
  • chronic pain
View approved original text

This medication is used to relieve moderate to severe acute and chronic pain.

How to take

Adult dose

Adults: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 1 tablet is recommended, and subsequent doses should be taken at intervals of at least 12 hours; do not exceed 4 tablets daily. Do not administer this medicine for longer than necessary. If prolonged administration is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued. Nausea, vomiting, itching, constipation, dizziness, and drowsiness may occur during administration; closely monitor the patient's response and adjust the dose as appropriate. Elderly: Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to elderly patients aged 75 years or older, administer this medicine at intervals of at least 12 hours. Patients with renal impairment: The safety and efficacy of this medicine have not been established in patients with renal impairment; therefore, its use is not recommended. Patients with hepatic impairment: The safety and efficacy of this medicine have not been established in patients with hepatic impairment; therefore, its use is not recommended.

Precautions

This drug may affect liver function, so individuals who regularly drink more than three alcoholic beverages a day should consult a doctor or pharmacist before taking it. One of the ingredients in this drug can rarely cause serious skin reactions, so if a rash or other allergic symptoms occur, discontinue use immediately. The main ingredient, tramadol, can increase the risk of seizures if taken in doses exceeding the recommended amount. Taking it with certain antidepressants or other central nervous system drugs may further increase the risk of seizures. Use with caution in patients with severe respiratory conditions, and administer in a location equipped with cardiopulmonary resuscitation equipment if necessary. Combining this drug with alcohol or benzodiazepines may result in severe drowsiness, respiratory depression, or coma, so such combinations should be avoided. Patients with head injuries or brain diseases should be cautious when using this drug, as respiratory suppression may increase intracranial pressure. This drug can cause psychological and physical dependence; therefore, long-term use requires careful monitoring for dependency and potential abuse. Patients with compromised liver function should consult a doctor before taking this medication due to the risk of liver damage. Particularly, patients with genetic variations affecting the metabolism of this drug may have an increased risk of respiratory suppression, requiring caution. This drug should not be administered to children under 12 years old or adolescents under 18 years old after certain surgeries, and adolescents between 12 and 18 years old should use it with caution. This drug can cause electrolyte imbalances known as hyponatremia, so elderly patients or those with risk factors should be closely monitored for symptoms. Patients with hypersensitivity to the ingredients or those on central nervous system drug detoxification, severe respiratory suppression, head injuries, or taking certain antidepressants should not take this medication. Pregnant or breastfeeding women should consult a doctor before taking this drug, and breastfeeding mothers should be especially cautious as the drug may be transmitted to the baby through breast milk. Drowsiness or dizziness may occur during driving or operating machinery, so caution is advised. Overdose may result in severe respiratory suppression or liver damage, so it is essential to strictly adhere to the dosage; in case of overdose, contact a medical institution immediately.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, muscle weakness, fatigue, flushing, chest pain, rigidity, syncope, withdrawal symptoms, hypertension, worsening hypertension, hypotension, arrhythmia, palpitations, tachycardia, dizziness, headache, tremor, ataxia, convulsions, hypertonia, migraine, exacerbation of migraine, involuntary muscle contractions, paresthesia, confusion, vertigo, abdominal pain, constipation, diarrhea, dyspepsia, flatulence, dry mouth, nausea, vomiting, dysphagia, hematochezia, tongue swelling, decreased appetite, anxiety, delirium, euphoria, insomnia, nervousness, drowsiness, forgetfulness, depersonalization, depression, drug abuse, dependence, emotional instability, hallucinations, erectile dysfunction, nightmares, abnormal thoughts, anemia, dyspnea, proteinuria, urination disorders, oliguria, urinary retention, pruritus, rash, sweating, urticaria, abnormal liver function, weight loss, tinnitus, abnormal vision, chills, vasodilation, orthostatic hypotension, bradycardia, collapse, myocardial ischemia, pulmonary edema, respiratory symptoms, bronchospasm, wheezing, angioedema, allergic reactions, anaphylaxis, Stevens-Johnson syndrome, appetite changes, muscular weakness, respiratory depression, cognitive dysfunction, difficulty concentrating, suicidal tendencies, hepatitis, liver failure, gastrointestinal bleeding, psychiatric side effects, prolonged prothrombin time, serotonin syndrome, exacerbation of asthma, withdrawal symptoms, delirium, miosis, mydriasis, speech disorders, motor disorders, hypoglycemia, hyponatremia, inappropriate secretion of antidiuretic hormone syndrome, thrombocytopenia, agranulocytosis, hypoprothrombinemia, fatigue, lactic acidosis, muscle weakness, fever, edema, rigidity, syncope, congestive heart failure, dizziness, confusion, exertional dyspnea, bronchitis, hematuria, increased blood pressure, palpitations, irregular menstruation, breast cancer, injury, bleeding, increased cholesterol, hip pain, thigh pain, allergic rhinitis, nosebleed, cholangiocarcinoma progression, foreign body sensation in the eye, hepatocellular carcinoma progression, paralytic ileus, hiccups, cholecystitis, memory disorders, lack of efficacy, facial flushing, heartburn, unspecified gastrointestinal disorders, acute gastritis, cold, upper respiratory tract infection, general weakness, motion sickness, transient ischemic attack, back pain, lethargy, withdrawal symptoms, panic attacks, severe anxiety, hallucinations, paresthesia, tinnitus, abnormal central nervous system reactions, urticaria, rash, bronchospasm, toxic skin necrosis, anaphylaxis, convulsions, serotonin syndrome, respiratory arrest, QT prolongation, renal tubular necrosis, hypoglycemia, coagulation disorders, withdrawal symptoms, adrenal insufficiency, pain sensitivity, withdrawal symptoms, drowsiness, dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the drug's efficacy and safety for a long time.

Appearance and packaging

Appearance

Light yellow oblong sustained-release film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.